Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.63B | 3.76B | 3.81B | 3.07B | 1.90B |
Gross Profit | 1.19B | 1.14B | 898.66M | 743.27M | 409.17M |
EBITDA | 750.97M | 719.36M | 616.36M | 441.89M | -496.66M |
Net Income | 320.27M | 314.24M | 154.97M | 113.30M | -742.35M |
Balance Sheet | |||||
Total Assets | 3.47B | 3.24B | 3.39B | 3.53B | 3.48B |
Cash, Cash Equivalents and Short-Term Investments | 507.68M | 288.56M | 250.19M | 251.68M | 201.42M |
Total Debt | 695.79M | 665.75M | 627.95M | 724.51M | 932.61M |
Total Liabilities | 1.64B | 1.58B | 1.71B | 1.78B | 1.86B |
Stockholders Equity | 1.85B | 1.68B | 1.69B | 1.77B | 1.63B |
Cash Flow | |||||
Free Cash Flow | 448.37M | 397.95M | 310.55M | 243.75M | 264.88M |
Operating Cash Flow | 589.68M | 540.27M | 413.36M | 328.22M | 310.04M |
Investing Cash Flow | -215.34M | -127.78M | -87.99M | -37.41M | 22.13M |
Financing Cash Flow | -150.46M | -373.17M | -324.81M | -234.35M | -175.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $14.63B | 16.86 | 29.27% | 0.57% | 12.15% | 91.88% | |
78 Outperform | $4.06B | 8.68 | 35.14% | 1.81% | -5.35% | -4.15% | |
75 Outperform | $18.20B | 9.99 | 18.16% | 3.22% | -4.08% | -29.26% | |
75 Outperform | $49.86B | 11.38 | 19.78% | 3.39% | 0.94% | -4.63% | |
71 Outperform | $4.52B | 10.00 | 7.31% | 4.19% | -1.21% | -54.44% | |
66 Neutral | $4.94B | 17.04 | 16.16% | 1.84% | -4.17% | -17.99% | |
56 Neutral | C$4.19B | 2.00 | 16.25% | 5.63% | 10.50% | -54.55% |
ChampionX has completed a merger with SLB, resulting in the termination of its existing credit agreement and the conversion of its common stock into SLB shares. As part of the merger, ChampionX’s stock was delisted from Nasdaq, and its directors and officers resigned, with new leadership from Merger Sub taking over. The merger also involved amendments to ChampionX’s corporate structure, including changes to its certificate of incorporation and bylaws.
The most recent analyst rating on (CHX) stock is a Buy with a $37.00 price target. To see the full list of analyst forecasts on ChampionX stock, see the CHX Stock Forecast page.
On June 10, 2025, ChampionX held its Annual Meeting where 89.8% of eligible voting shares were represented. During the meeting, eight directors were elected to serve until the 2026 annual meeting, PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm, and the compensation of the company’s named executive officers for 2024 was approved on an advisory basis.
The most recent analyst rating on (CHX) stock is a Buy with a $37.00 price target. To see the full list of analyst forecasts on ChampionX stock, see the CHX Stock Forecast page.